Septic Shock News and Research

RSS

Flesh-eating bacteria on Texas beach leaves man fighting for his life

Steve Gilpatrick went swimming while on holiday in early July at Crystal Beach, when the ulcer had apparently almost healed; his leg became infected three days later and he developed a high fever and was taken to hospital.

21 Jul 2007

Tiny turtle responsible for baby's death

The Centers for Disease Control and Prevention (CDC) in the United States has linked the death of a four-week-old baby in Florida earlier this year to a pet turtle.

9 Jul 2007

Early identification and aggressive treatment of sepsis has the potential to improve outcomes

More than 215,000 people will die of sepsis in the United States each year, more than 750,000 will require hospital treatment, and the costs will be nearly $17 billion.

17 May 2007

Effect of hydrocortisone treatment modality on glycemic control in patients with septic shock

Changing how critically ill patients are treated with hydrocortisone could reduce hyperglycemia.

18 Feb 2007

New understanding of blood pressure gene could lead to new treatments

Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer.

5 Feb 2007

New drug to treat kidney failure during septic shock

Research from Melbourne's Howard Florey Institute and the Austin Hospital has resulted in a drug to treat kidney failure during septic shock, which will be trialled at the Austin Hospital from mid-2007.

29 Jan 2007

Antibiotic doses could be reduced by up to 50 times using new approach

Steven Hagens, previously at the University of Vienna, told Chemistry & Industry, the magazine of the SCI, that certain bacteriophages, a type of virus that infects bacteria, can boost the effectiveness of antibiotics gentamicin, gramacidin or tetracycline.

29 Jan 2007

New treatment for septic shock

A potential new treatment for septic shock and other inflammatory diseases has been discovered by Monash Institute researchers.

14 Aug 2006

Periodic 'deep inflation' helps prevent ventilator-induced lung injury

Ventilation therapy burst into the public consciousness more than 60 years ago with the "iron lung" and the polio epidemic.

26 Jul 2006

Method by which Caspase-12 shuts down the body's immune system discovered

Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.

28 Apr 2006

Caspase-12 antagonists could potentially be useful in the treatment of sepsis and other inflammatory and immune disorders

According to the new study, the presence of caspase-12, which appears to modulate inflammation and innate immunity in humans, increases the body's "vulnerability to bacterial infection and septic shock" while a deficiency confers strong resistance to sepsis. This new discovery suggests that caspase-12 antagonists could be a potentially useful in the treatment of sepsis and other inflammatory and immune disorders.

26 Apr 2006

Kidney treatments may be improved with new understanding of cell death mechanism

Finding how two proteins conspire to get kidney cells to self-destruct when oxygen supplies are low may one day improve dismal mortality rates for ischemic renal failure, researchers say.

23 Apr 2006

Nrf2 gene findings may offer therapeutic potential for sepsis treatment

Disruption of a single gene, Nrf2, plays a critical role in regulating the body's innate immune response to sepsis and septic shock, according to a study by a research team led by Shyam Biswal, PhD, at the Johns Hopkins Bloomberg School of Public Health.

4 Apr 2006

New molecular target for potential drugs to treat acute respiratory distress syndrome

Researchers at the University of Virginia Health System have identified a molecular target, or receptor, for potential drugs to treat acute respiratory distress syndrome (ARDS), a sudden and life-threatening failure of the lung.

23 Feb 2006

Protein levels predict bone marrow transplant survival

Researchers say that protein levels can predict which bone marrow transplant patients are likely develop a deadly complication a week after the procedure and well before any symptoms occur.

19 Feb 2006

Protein level predicts who will develop graft vs. host disease after marrow transplant

Researchers could determine one week after a bone marrow transplant which patients were likely to develop a serious and deadly complication, making them candidates for preventive treatment before any symptoms occur.

17 Feb 2006

Researchers "should rethink what they are doing" in creating drugs based on a fruit-fly model

The first close-up look at a pro-inflammatory signaling molecule involved in immune response in mammals suggests that researchers "should rethink what they are doing" in creating drugs based on a fruit-fly model, scientists say.

4 Oct 2005

Lack of oxygen in body tissues creates a defect of red blood cells that further exacerbates the condition by constricting blood vessels in the lung

What's more, the team demonstrated through studies in people and animals that inhalation of a 'souped up' form of nitric oxide, which targets red blood cells, reverses the blood abnormality to restore normal lung pressure.

3 Oct 2005

Research may help create drugs to target the molecule-binding pathway, beneficial for treating arthritis and reducing inflammation